Goldman Sachs raised the firm’s price target on Tarsus Pharmaceuticals (TARS) to $41 from $36 and keeps a Neutral rating on the shares.

H.C. Wainwright raised the firm’s price target on Tarsus Pharmaceuticals (TARS) to $73 from $61 and keeps a Buy rating on the shares. The ...

Five ways to help employees find purpose at work. Discover how conversations, job rotations, curiosity, and learning ...

In the fast-paced world of pharmaceuticals, sales intelligence for the pharmaceutical sector has become an indispensable tool for companies aiming to maintain a competitive edge. As the industry ...

Rieger and Kirby will help oversee and implement operational changes, which were announced last month, including reducing its number of sales territories and cutting jobs. These changes, expected to ...

Novartis expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan said in an ...

West Pharmaceutical Services reported a slight decline in third-quarter 2024 net sales to $746.9 million and a drop in adjusted earnings per share to $1.85 from $2.16 last year. Despite these ...

a day after the Japanese automaker said it would cut 9,000 jobs and 20% of its manufacturing capacity as it struggles with sales in China and the United States. Technologycategory SMIC sees ...

GAAP EPS for the quarter was $1.85, down 13.6% year over year. West Pharmaceutical registered net sales of $746.9 million, down 0.1% year over year. The figure, however, beat the Zacks Consensus ...

Takeda, a Japanese pharmaceutical company with US headquarters ... In late June, the company reported to the state it was cutting 189 more jobs in Cambridge and 31 in Lexington.

Domino Printing Sciences has launched a suite of new enhancements for its K600G variable data printing solution, designed for pharmaceutical manufacturers individual dose serialisation. The K600G ...